By Will Feuer


Abbvie Inc. Vice Chairman Michael Severino is leaving the company, effective May 31, to join bioplatform innovation firm Flagship Pioneering as chief executive-partner, the companies said.

Dr. Severino will also serve as CEO of one of Flagship's companies, which hasn't yet been announced, the company said.

"I look forward to applying my experience across all phases of drug discovery, development, and commercialization at Flagship, to help make an important difference for patients," Dr. Severino said.

Dr. Severino joined AbbVie in 2014 as executive vice president of research and development and chief scientific officer. Before joining AbbVie, Dr. Severino was corporate chief medical officer at Amgen Inc.

Flagship Pioneering, founded by Noubar Afeyan in 2000, has invested billions in dozens of bipharmaceutical firms, including various public companies like Axcella Health Inc., Codiak BioSciences Inc. and others.


Write to Will Feuer at Will.Feuer@wsj.com


(END) Dow Jones Newswires

04-13-22 1004ET